ClinicalTrials.Veeva

Menu

OCT Vibrography for Biomechanical Properties of Tissues

Mass General Brigham logo

Mass General Brigham

Status

Enrolling

Conditions

Gingival Diseases
Skin Diseases
Cornea

Treatments

Device: Optical imaging of the tissues

Study type

Interventional

Funder types

Other

Identifiers

NCT05759780
2023P000338

Details and patient eligibility

About

The overall goal of this study is to develop OCT Vibrography (aka OCT elastography) as a novel tool for measuring biomechanical properties of human tissues in vivo.

Full description

The overall goal of this study is to develop OCT Vibrography (aka OCT elastography) as a novel tool for measuring biomechanical properties of human tissues in vivo. The investigators aim to establish baseline data in healthy subjects, compare elastic moduli in different tissue types, and measure differences in elastic moduli between keratoconus and normal eyes. If successful, this project will provide useful, previously inaccessible elastic parameters and advance the investigators' understanding of the relationship between the bulk mechanical properties and the microstructure of the human tissue in vivo. This information can ultimately be used to improve the diagnosis and treatment of keratoconus, inflammatory skin diseases, and inflammatory gingiva diseases. More broadly, the technologies developed in this project will have relevance to other potential applications beyond the tissues in this research study.

Enrollment

90 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Group 1:

Inclusion criteria:

• Subjects with healthy eyes (age 18 - 75, N = 50)

Exclusion criteria:

  • Subjects with history of eye diseases, and previous eye surgeries.
  • Subjects with diabetes, glaucoma family history
  • Subjects allergic to anesthetic eyedrop, especially proparacaine
  • Subjects with severe allergy
  • Subjects who have difficulty biting
  • Subjects who have recurrent corneal erosion

Group 2:

Inclusion criteria:

• Subjects with healthy skin (age 18 - 75, N = 10)

Exclusion criteria:

• Subjects with open cuts/sores on the skin, skin infection, or any contagious skin condition

Group 3:

Inclusion criteria:

• Subjects with healthy gingiva (age 18 - 75, N = 10)

Exclusion criteria:

• Subjects with open cuts/sores on the gingiva, gingiva infection, or any contagious gingiva condition

Group 4:

Inclusion criteria:

• Mild or moderate keratoconus subjects (age 18 - 40, N = 20)

Exclusion criteria:

• Subjects with K-max above 60 diopters (Pentacam imaging) are excluded

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

90 participants in 4 patient groups

Healthy cornea
Experimental group
Description:
Optical imaging of the cornea in healthy subjects
Treatment:
Device: Optical imaging of the tissues
Healthy skin
Experimental group
Description:
Optical imaging of the skin in healthy subjects
Treatment:
Device: Optical imaging of the tissues
Healthy gingiva
Experimental group
Description:
Optical imaging of the gingiva in healthy subjects
Treatment:
Device: Optical imaging of the tissues
Keratoconus cornea
Experimental group
Description:
Optical imaging of the cornea in mild and moderate keratoconus
Treatment:
Device: Optical imaging of the tissues

Trial contacts and locations

1

Loading...

Central trial contact

Jing Zhang, PhD; Seok-Hyun Yun, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems